Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Agency For International Development was posted on December 24, 2003. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

65 -- Depo-Provera, an Injectable Contraceptive

Closed
M-OP-GH-POP-04-326Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

N/A

Place of Performance

100 Route 206 North Peapack, NJ 07977 07977, DC

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyAgency For International Development → Usaid M/oaa
Contacts1 person available
OfficeWASHINGTON, DC, 20004, USA
Office AddressWASHINGTON, DC, 20004, USA
Contacts
AlfredaWilson - ThomasNegotiator

Full Description

Show more
This is a notice of intent to negotiate a non-competitive contract with Pfizer Global Pharmaceuticals, 100 Route 206 North Peapack, NJ 07977. The U.S. Agency for International Development (USAID) has a requirement for 10,000,000 vials of Depo-Provera and a like number of single-use auto-disable syringes and needles and four Sharps containers per carton for delivery from January 2005 through December 2005 with an option to purchase up to 20,000,000 additional vials during this period. The contract shall include four one-year options that will extend the contract through December 31, 2009. As Pfizer Global Pharmaceuticals is the only U.S. FDA-approved source for the manufacturer of the inject able contraceptive Depo-Provera product, USAID intends to negotiate a contract with this organization on a sole-source basis. Please direct all inquiries in writing regarding this procurement to the contact point above.

More opportunities from Agency For International Development → Usaid M/oaa

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS